Floatz logo

pf-04691502

Advanced Breast Cancer (Phase 1b)

PfizerSmall moleculePhase 2Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
31/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Advanced Breast Cancer (Phase 1b) cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

pf-04691502 is also rated in:

breast cancerDormant
CC
Indicative ·
46 / 100
View asset →
breast neoplasmDormant
CC
Indicative ·
44 / 100
View asset →
cancerDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →